UP!

AGTC $70   View long term graphs

Applied Genetic Technologies Corporation
Type
Public company
Traded as NASDAQ: AGTC
Industry Biotechnology
Founded 1999
Headquarters Alachua, Florida
Website www.agtc.com

The Applied Genetic Technologies Corporation is a publicly traded (NASDAQ:AGTC) biotechnology company that is part of the NASDAQ Biotechnology Index. It was founded in 1999 and has its headquarters in Alachua, Florida.

The company focuses on ophthalmologic genetic diseases. The company's technologies are aimed at products that might have the potential to treat achromatopsia, X-linked retinoschisis, X-linked retinitis pigmentosa, and age-related macular degeneration. The company has six products in various stages of development; as of 2016, none had yet been approved.


News

Applied Genetic Technologies Corporation -3.28% (healthcare)

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q2 2021 2021-02-08 Future report Set alerts
Q1 2021 2020-11-11 Future report Set alerts
Q4 2020 2020-09-09 -0.56 -0.56
Q3 2020 2020-05-13 -0.50 -0.50
Q2 2020 2020-02-05 -0.47 -0.47
Q1 2020 2019-11-12 -0.64 -0.64
Q4 2019 2019-09-26 -0.58 -0.58
Q3 2019 2019-05-07 0.63 0.63
Q2 2019 2019-02-07 -0.23 -0.23
Q1 2019 2018-11-08 0.07 0.07

Ratings

2016-06-22 Reiterated Rating Cantor Fitzgerald Buy $32.00
2016-05-10 Reiterated Rating Wedbush Outperform $36.00
2016-05-10 Reiterated Rating Wells Fargo Buy
2016-05-10 Reiterated Rating Cantor Fitzgerald Buy $32.00
2016-05-10 Reiterated Rating Wells Fargo & Co. Buy
2016-04-25 Reiterated Rating Roth Capital Buy
2016-04-11 Initiated Coverage BMO Capital Markets Outperform $25.00
2016-03-18 Initiated Coverage Janney Montgomery Scott Buy $23.00
2016-02-09 Lower Price Target Stifel Nicolaus Buy $32.00 to $29.00
2016-02-09 Reiterated Rating Cantor Fitzgerald Buy $32.00
2016-01-10 Reiterated Rating Chardan Capital Buy $25.00
2015-12-17 Reiterated Rating Cantor Fitzgerald Buy $32.00
2015-12-11 Reiterated Rating Cantor Fitzgerald Buy $32.00
2015-12-03 Initiated Coverage Wells Fargo Outperform
2015-10-05 Reiterated Rating Cantor Fitzgerald Buy to Buy $32.00
2015-09-11 Reiterated Rating Roth Capital Buy $34.00
2015-09-11 Reiterated Rating Wedbush Outperform $36.00
2015-09-11 Reiterated Rating Cantor Fitzgerald Buy $32.00
2015-08-30 Reiterated Rating Chardan Capital Buy $25.00
2015-08-28 Reiterated Rating Roth Capital Buy $34.00
2015-07-22 Initiated Coverage Chardan Capital Buy $25.00
2015-07-06 Boost Price Target Cantor Fitzgerald Buy $28.00 to $32.00
2015-07-03 Reiterated Rating BMO Capital Markets Outperform $34.00 to $42.00
2015-07-02 Reiterated Rating Roth Capital Buy $34.00
2015-06-23 Set Price Target Wedbush Buy $36.00
2015-06-23 Set Price Target Roth Capital Buy $34.00
2015-06-23 Reiterated Rating Cantor Fitzgerald Buy $28.00
2015-05-05 Set Price Target Roth Capital Buy $34.00
2015-05-05 Set Price Target Cantor Fitzgerald Buy $28.00
2015-03-26 Reiterated Rating Cantor Fitzgerald Buy $28.00
2015-03-11 Reiterated Rating Cantor Fitzgerald Buy $28.00
2015-02-12 Reiterated Rating Cantor Fitzgerald Buy $28.00
2014-11-13 Reiterated ROTH Capital Buy $25 to $34
2014-11-13 Boost Price Target Cantor Fitzgerald Buy $24.00 to $28.00
2014-11-13 Boost Price Target Stifel Nicolaus Buy $29.00 to $31.00
2014-11-13 Boost Price Target Roth Capital Buy $25.00 to $34.00
2014-10-03 Reiterated Rating Wunderlich Buy $29.00
2014-10-03 Initiated Coverage Stifel Nicolaus Buy $29.00
2014-08-21 Boost Price Target Cantor Fitzgerald Buy $21.00 to $24.00
2014-06-09 Boost Price Target BMO Capital Markets Outperform $21.00 to $34.00
2014-04-21 Initiated Coverage Roth Capital Buy
2014-04-21 Initiated Coverage Wedbush Outperform
2014-04-21 Initiated Coverage Cantor Fitzgerald Buy $21.00
2014-04-21 Initiated Coverage BMO Capital Markets Outperform $14.08
2016-06-22 Reiterated Rating Cantor Fitzgerald Buy $32.00
2016-05-10 Reiterated Rating Wedbush Outperform $36.00
2016-05-10 Reiterated Rating Wells Fargo Buy
2016-05-10 Reiterated Rating Cantor Fitzgerald Buy $32.00
2016-05-10 Reiterated Rating Wells Fargo & Co. Buy

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
Carroll Jill 14.13%  (1989598) AGTC /
Alta Partners VIII, L.P. 10.60%  (1492200) AGTC / ESPR / IMDZ / NEOT / TRVN / ZSPH /
INTERWEST PARTNERS VIII LP 10.32%  (1452216) AGTC / MGNX /
MedImmune Ventures, Inc. 10.32%  (1452196) AGTC /
Wu Samuel 10.32%  (1452196) AGTC /
GLAXOSMITHKLINE PLC 10.20%  (1436448) AGTC / CNCE / FOLD / GNCA / OMED / PATH / TBPH / THRX /
Rosen James 8.56%  (1205537) AGTC /
Feinsod Matthew Interim Chief Medical Officer 0.28%  (39377) AGTC /
ORONSKY ARNOLD L 0.08%  (11208) AGTC / DVAX / MGNX / TSRO /
Chulay Jeffrey D. V.P. & Chief Medical Officer 0.07%  (9900) AGTC /
HURWITZ EDWARD 0.01%  (1800) AGTC / CARA / MGNX / SNSS /

Comments